Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02180711
Title An Open-label, Phase 1b Study of ACP 196 in Subjects With Follicular Lymphoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Acerta Pharma BV
Indications

non-Hodgkin lymphoma

Therapies

Acalabrutinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.